Berliner Boersenzeitung - Natural immunity more potent than vaccines during US Delta wave: study

EUR -
AED 4.242245
AFN 75.654532
ALL 93.325519
AMD 422.942357
AOA 1059.262039
ARS 1728.414775
AUD 1.636649
AWG 2.079249
AZN 1.966445
BAM 1.956746
BBD 2.325324
BDT 142.909084
BHD 0.435409
BIF 3445.050474
BMD 1.155138
BND 1.480416
BOB 14.021475
BRL 5.929904
BSD 1.154558
BTN 109.759584
BWP 15.656501
BYN 3.414651
BYR 22640.712839
BZD 2.321972
CAD 1.619464
CDF 2610.61251
CHF 0.932426
CLF 0.026751
CLP 1056.327434
CNY 7.801285
CNH 7.794025
COP 3684.972388
CRC 523.553093
CUC 1.155138
CUP 30.611168
CVE 110.318329
CZK 24.185945
DJF 205.581372
DKK 7.475951
DOP 67.33255
DZD 153.427453
EGP 57.552814
ERN 17.327076
ETB 186.341747
FJD 2.553022
FKP 0.858526
GBP 0.85735
GEL 3.015253
GGP 0.858526
GHS 13.536016
GIP 0.858526
GMD 85.480763
GNF 10140.902255
GTQ 8.806257
GYD 241.50734
HKD 9.060848
HNL 30.944959
HRK 7.535202
HTG 150.952973
HUF 361.642075
IDR 20621.530898
ILS 3.469747
IMP 0.858526
INR 109.753455
IQD 1512.43113
IRR 1588459.705816
ISK 141.815708
JEP 0.858526
JMD 183.468691
JOD 0.818964
JPY 181.916396
KES 149.440027
KGS 101.0169
KHR 4679.241757
KMF 494.399724
KRW 1643.149575
KWD 0.357204
KYD 0.962161
KZT 541.779559
LAK 26098.051339
LBP 103385.040277
LKR 387.427288
LRD 208.389837
LSL 18.940556
LTL 3.410824
LVL 0.698732
LYD 7.348552
MAD 10.760502
MDL 20.05961
MGA 4914.26927
MKD 61.559759
MMK 2424.984769
MNT 4156.41639
MOP 9.327369
MRU 46.29638
MUR 54.279962
MVR 17.8581
MWK 2001.889755
MXN 19.879863
MYR 4.729249
MZN 73.808421
NAD 18.940556
NGN 1573.448369
NIO 42.490541
NOK 10.989496
NPR 175.616656
NZD 1.963302
OMR 0.444142
PAB 1.154533
PEN 3.908289
PGK 5.176502
PHP 70.003118
PKR 320.581474
PLN 4.299373
PYG 6885.328464
QAR 4.22094
RON 5.247563
RSD 117.352814
RUB 93.537754
RWF 1696.012535
SAR 4.33469
SBD 9.323758
SCR 15.493821
SDG 693.672599
SEK 10.949522
SGD 1.479507
SLE 27.607866
SOS 659.821823
SRD 43.511783
STD 23909.032875
STN 24.511849
SVC 10.101883
SZL 18.925231
THB 38.212042
TJS 10.656021
TMT 4.054536
TND 3.387638
TRY 54.956167
TTD 7.831786
TWD 37.301841
TZS 3061.11446
UAH 51.665276
UGX 4306.08162
USD 1.155138
UYU 46.422441
UZS 13724.634681
VES 871.218385
VND 30323.538404
VUV 138.112979
WST 3.161328
XAF 656.27141
XAG 0.018521
XAU 0.000272
XCD 3.121819
XCG 2.080715
XDR 0.817207
XOF 656.274252
XPF 119.331742
YER 275.327055
ZAR 18.833613
ZMK 10397.632497
ZMW 22.039177
ZWL 371.954097
  • RYCEF

    0.6500

    21

    +3.1%

  • GSK

    0.0700

    51.6

    +0.14%

  • CMSC

    -0.0350

    21.755

    -0.16%

  • BTI

    -0.0400

    59.08

    -0.07%

  • RELX

    -0.1330

    36.667

    -0.36%

  • VOD

    -0.3400

    15.35

    -2.21%

  • AZN

    6.7700

    162.39

    +4.17%

  • RIO

    2.3450

    101.355

    +2.31%

  • BCE

    -0.1650

    21.835

    -0.76%

  • NGG

    -0.2000

    80.22

    -0.25%

  • BP

    -0.6850

    41.755

    -1.64%

  • BCC

    -1.5700

    84.92

    -1.85%

  • CMSD

    -0.0200

    22

    -0.09%

  • JRI

    -0.0600

    12.66

    -0.47%

  • RBGPF

    -1.2500

    69.74

    -1.79%

Natural immunity more potent than vaccines during US Delta wave: study
Natural immunity more potent than vaccines during US Delta wave: study

Natural immunity more potent than vaccines during US Delta wave: study

During America's last surge of the coronavirus driven by the Delta variant, people who were unvaccinated but survived Covid were better protected than those who were vaccinated and not previously infected, a new study said Wednesday.

Text size:

The finding is the latest to weigh in on a debate on the relative strengths of natural versus vaccine-acquired immunity against SARS-CoV-2, but comes this time with the imprimatur of the US Centers for Disease Control and Prevention (CDC).

The authors of the paper warned, however, against depending on infection as a strategy, given the higher risks to unvaccinated persons who weren't previously infected of hospitalization, long term impacts, and death, compared to vaccinated people.

Indeed, by November 30, 2021, some 131,000 residents of California and New York had died from Covid-19, the two states the paper, which used statistical modeling, was based on.

"Viruses are constantly changing, including the virus that causes Covid-19," the CDC said in a statement.

"The level of protection offered by vaccination and surviving a previous infection changed during the study period. Vaccination remains the safest strategy for protecting against Covid-19," it added.

The analysis was also carried out before the emergence of the Omicron variant, for which both vaccine and infection-derived immunity appear diminished, and before boosters were made widely available.

It used case data from 1.1 million people who tested positive in New York and California between May 30 to November 30, 2021, and used that to model inferences about the wider population.

Prior to Delta becoming dominant, vaccination conferred greater immunity than infection. But the relationship shifted when the variant became predominant in late June and July.

- Selection bias? -

By the week of October 3, vaccinated people who did not have prior Covid were three to four times (in California and New York, respectively) more likely to be infected than unvaccinated people with prior Covid.

In the weeks of October 13 to November 14, vaccinated people who did not have prior Covid in California, were around three times more likely to be hospitalized than unvaccinated people with prior Covid.

Protection was highest among those who had both vaccination and prior Covid.

The study could however be impacted by an effect known as "selection bias," since it excluded people who died, who were overwhelmingly unvaccinated.

Other research, including a notable paper from Israel in August, have also found that natural immunity was more potent than vaccines during the Delta surge.

But the US CDC had previously taken the opposite position, based on pre-Delta data.

"Further studies are needed to establish duration of protection from previous infection by variant type, severity, and symptomatology, including for the Omicron variant," the paper concluded.

(G.Gruner--BBZ)